Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$6,374,970
+$1,467,998 QoQ
Shares Held
5,315
-0.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,532
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Analysts, LLC holds $29,659,281 across 14 Drug Manufacturers - General names. LLY ranks #3 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
72,378 | $9,300,573 | |
| 2 | JNJ |
Johnson & Johnson
|
32,347 | $8,215,167 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
5,315 | $6,374,970 | |
| 4 | ABBV |
AbbVie Inc.
|
7,055 | $1,775,319 | |
| 5 | AMGN |
Amgen Inc
|
3,021 | $1,093,963 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,923 | $874,651 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
11,930 | $687,405 | |
| 8 | NVS |
Novartis AG
|
4,070 | $637,849 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,374,970 | 5,315 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $4,906,972 | 5,335 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $2,123,567 | 1,976 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $1,516,081 | 1,987 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,625,319 | 2,085 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,769,099 | 2,142 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,746,004 | 3,557 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,379,633 | 2,686 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $959,702 | 1,060 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $812,190 | 1,044 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $631,885 | 1,084 | Shares | Defined | 2024-01-30 | |
| 2023-09-30 | $603,196 | 1,123 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $490,083 | 1,045 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $117,449 | 342 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $109,385 | 299 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $100,238 | 310 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $91,756 | 283 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $81,042 | 283 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $78,169 | 283 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $65,386 | 283 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $66,789 | 291 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $54,176 | 290 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $39,508 | 234 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $34,932 | 236 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $38,746 | 236 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $32,737 | 236 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||